Eleusis, the world’s first legal luxury psychedelic immersion, will officially debut in March 2026 on the island of Bequia in Saint Vincent and the Grenadines. Built on a single foundational principle — safety first — Eleusis offers a licensed, research immersion in a physician-supervised environment, set within a private tropical wellness sanctuary. Eleusis is now accepting applications for the March 2026 cohort, with private inquiries welcomed.
Founded by Christina Thomas, chief experience officer; Angus Taylor, CEO; Charles Patti, chief of purpose; and Craig Stenhouse, chief operating officer, Eleusis is a curated experiential sanctuary designed for rigorous, responsible consciousness exploration. Eleusis is not a clinic, not a consumer wellness product, and not a traditional retreat — it is a medically-supervised research immersion created for experienced participants seeking a discreet, high-touch environment and a deeply structured program.
Developed by Dr. Andrew Gallimore in conjunction with Dr. Rick Strassman, DMTx technology has been explored in institutional research settings, including work associated with Imperial College London, and Yale University, and has been described in published research as safe and tolerable under controlled conditions.
DMTx is an extended-state DMT experience enabled through controlled administration. DMT is a short-acting psychedelic compound that has been studied for its relationship to perception and consciousness. Using a target-controlled IV (TCIV) infusion to maintain a stable and regulated level over time, DMTx is designed to support a sustained, structured experience for observation, exploration, and integration — within defined medical and operational protocols.
At Eleusis, DMTx protocols are physician-supervised and supported by a trained care team, with monitoring and participant support designed around best practices in screening, preparation, and integration. Eleusis follows a precision-minded approach, including customized dosing parameters and structured pre/post experience support.
Eleusis Performance Programs
- Flow: Flow state is total mental focus — merging mind and body for elevated execution. Flow training is designed to support leadership, creativity, collaboration, and performance. The team tracks brainwave activity using EEG to help participants build awareness and cultivate “flow on-demand” practices.
- Create: Designed to help participants access subconscious insight and translate it into tangible output, Create supports creative breakthroughs through visual art, design, animation, and music production — with guided structure and integration.
Eleusis provides a comprehensive range of amenities and services, including ten private villas, biometric tracking, EEG technologies, personalized care and nutrition regimens, individual preparation and integration support, and curated wellness programming. Each villa features floor-to-ceiling windows, private pools, and panoramic ocean views.
At Eleusis’ farm-to-table restaurant, every dish is crafted with organic, locally sourced ingredients and fresh-caught seafood. A low-inflammation food program is designed to nourish the body and support the overall experience.
“We exist to empower pioneers, visionaries, and seekers to heal, create, expand, and lead from an awakened state,” said Taylor. “By integrating insights from inner experience with purposeful action in the world, we aim to help normalize responsible consciousness exploration — with safety and integrity at the center.”
“Eleusis represents a new chapter in self-discovery and responsible exploration,” said Patti. “My own experiences changed the trajectory of my life. Eleusis is my way of creating a safe, structured space where others can explore intentionally, with the right medical oversight and integration support.”
“DMT is one of the most powerful tools for exploring the furthest reaches of consciousness, and DMTx transforms what was once a transient encounter into a platform for structured exploration,” said Gallimore. “From the beginning, my vision was that DMTx could move beyond research institutions and become accessible to those who wish to explore responsibly and intentionally. With Eleusis, that vision is now taking form.”
Curated Expert & Care Leadership
Eleusis brings together a globally respected interdisciplinary team, including Dr. Andrew Gallimore, PhD—inventor of DMTx and computational neurobiologist; Dr. Chris Timmermann, PhD—director of research, neuroscientist, and DMT phenomenology researcher (University College London); Alex Tomic—technology entrepreneur and research funder; Dr. Andrew Ferber, MD—psychiatry and integrative mental health; Bianca Abbott, NP—advanced practice nursing, with a focus on detox and fasting; Dr. Murray Heber, DC—director of flow and performance, neuroscience of performance and flow-state training; and Christina Thomas—chief experience officer, overseeing participant experience and integration and COO and co-founder of MY Self Wellness.
For more information and to apply, visit www.eleusismind.com. Private inquiries and media requests may be directed to Eleusis@dureeandcompany.com.
About Eleusis:
Eleusis, located on the serene island of Bequia in Saint Vincent and the Grenadines, Caribbean, is the world’s first legal luxury psychedelic research immersion utilizing DMTx protocols and novel compounds in a safety-first, physician-supervised environment. The name is drawn from Eleusis, an ancient site near Athens, Greece, where the Eleusinian Mysteries transformed the lives of participants from all walks of life. For more information, visit www.eleusismind.com.
###
